Biblio
Export 51 results:
Author [ Title] Type Year Filters: First Letter Of Title is O [Clear All Filters]
“Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1059-1071, 2022.
, “An Objective Method to Accurately Measure Cardiorespiratory Fitness in Older Adults Who Cannot Satisfy Widely Used Oxygen Consumption Criteria.”, J Alzheimers Dis, vol. 61, no. 2, pp. 601-611, 2018.
, “Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1721-1730, 2018.
, “Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.”, J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
, “Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.”, J Alzheimers Dis, vol. 55, no. 1, pp. 283-292, 2017.
, “Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene.”, J Alzheimers Dis, vol. 49, no. 1, pp. 27-30, 2016.
, “Odor Discrimination as a Marker of Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1169-1178, 2023.
, “Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1759-1766, 2018.
, “Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
, “Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 75, no. 3, pp. 845-854, 2020.
, “Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1497-1507, 2017.
, “Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1045-1055, 2017.
, “O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1195-1211, 2019.
, “Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.”, J Alzheimers Dis, vol. 50, no. 3, pp. 779-89, 2016.
, “Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.”, J Alzheimers Dis, vol. 75, no. 1, pp. 187-199, 2020.
, “Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 1, pp. 51-66, 2022.
, “Olfactory Dysfunction in ApoE ε4/4 Homozygotes with Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Olfactory Function is Associated with Cognitive Performance: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 319-329, 2018.
, “Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 2, pp. 547-57, 2016.
, “One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 2, pp. 841-853, 2021.
, “One-Year Evolution of Behavioral and Psychological Symptoms of Dementia in Patients Initially Hospitalized in Cognitive Behavioral Units: The EVITAL Prospective Cohort.”, J Alzheimers Dis, vol. 57, no. 1, pp. 147-155, 2017.
, “The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 11-3, 2016.
, “Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1293-1299, 2017.
, “An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”, Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
, “Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1101-1107, 2017.
,